The ART BMC System by Celling Biosciences Is Revolutionizing the Practice of Cell Therapy
The new ART BMC bone marrow concentration system used in Adult Stem Cell Therapies is leading the biotechnology industry.
AUSTIN, Texas, May 7, 2016 /PRNewswire/ -- The ART BMC bone marrow concentration systems are best-in-class devices for the point-of-care concentration of bone marrow aspirate (BMA). The systems recover the greatest percentage of nucleated and progenitor cells by allowing selection of the cell concentrate from user-defined portions of the centrifuged stack.
Photo - http://photos.prnewswire.com/prnh/20160506/364790
The new system by Celling Biosciences concentrates autologous bone marrow aspirate effectively and efficiently at the point-of-care in 15 minutes. Essential cell, growth factors and proteins are found within the stratified stack of the bone marrow concentrate. The dual capture system of the ART BMC Plus allows users to selectively deconstruct the stack in order to optimize the composition of the final preparation (e.g. BMC, fibrinogen, etc).
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
SOURCE Celling Biosciences
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article